Portfolio Company · Operating Co.

RX-Post

Healthcare · Website

backed bySlauson & Co.

CurrentHealthcare

RX-Post

a portfolio company of

Slauson & Co.

Status on record: Current

PE Firm Index

Who owns RX-Post?

RX-Post is listed as a current portfolio company of Slauson & Co. on Slauson & Co.'s own portfolio page.

From the company's website

Cut drug-stock costs up to 30% and turn surplus into cash. RxPost links licensed pharmacies-single stores to 50-store chains-in a DSCSA-compliant marketplace.

Source: rx-post.com, read November 2026

Company Snapshot

RX-Post is a Healthcare company. Its owner on record, Slauson & Co., is a firm. Slauson & Co. lists 38 companies in the index, 1 of them in Healthcare.

SectorHealthcare

Parent PE firmSlauson & Co.

Ownership statusCurrent

WebsiteVisit ↗

About the owner

Slauson & Co.

Companies in the index: 38

Early-stage venture capital firm focused on economic inclusion.

Read the Slauson & Co. profile

Questions about RX-Post

Who owns RX-Post?

RX-Post is listed as a current portfolio company of Slauson & Co. on Slauson & Co.'s own portfolio page.

What sector is RX-Post in?

RX-Post is in Healthcare. Classified from the company's own description.

What is RX-Post's website?

RX-Post's website is https://www.rx-post.com/.

Sources

Slauson & Co.
https://www.slauson.co/home/

This profile is based on publicly available information and may be incomplete or outdated. PE Firm Index is not affiliated with RX-Post and does not provide investment advice.

Other portfolio companies of Slauson & Co.

6 of 37 shown

See the full Slauson & Co. portfolio.

Other Healthcare portfolio companies

via Wavemaker 360 Health

3P Biopharmaceuticals

via Marlin Equity Partners

Browse PE-backed companies.

Is this your company?

Claiming is free and reviewed by hand. Correct facts and add your team.

Claim this profile Suggest a correction

Ownership

Parent PE firm

Slauson & Co.

Status: Current

Check this company's website

Check this company's website now

Free, in about two minutes: the verified issues a buyer or a customer's browser would meet. Runs on GTM Brain, by DevriX.

Observational measurements of this company's public website only. Not a rating of the company, its performance, its management, or its investment merit. Not investment advice. Request a correction or removal via Submit Update.

For PE-backed companies

DevriX

DevriX runs the websites, integrations and data that bring in revenue, as one accountable engineering and operations team, through acquisitions and exit.

Where DevriX helps

Value creation through the holdRevenue, data, web and AI run as one operating cadence, tied to EBITDA.Add-ons and carve-outsConsolidate or separate platforms and unify reporting after a deal.Exit readinessFind the technology and data issues a buyer's diligence would raise, before it does.

Send DevriX a short brief

A short form on devrix.com. No call to book.

Disclosure: PE Firm Index is maintained by Mario Peshev, who founded and runs DevriX. DevriX listing

Weekly PE M&A and market research, by email

The Growth Shuttle Insider is Mario Peshev's weekly newsletter for PE owners and operators. Each issue carries the week's private equity deals from this index, market data and research, and an essay from Mario.

Free. One email a week. Unsubscribe from any issue. Your address goes to beehiiv, the service that sends the Insider.

Research

The 2027 Digital Value Creation Baseline

1,407 PE-backed companies from 179 sponsors, measured from public sources in October 2026. 15% of service and product companies have the full path from search to CRM.

Read the research

Research by Growth Shuttle and DevriX.